365 related articles for article (PubMed ID: 17917875)
41. Adoptive cellular immunotherapy for viral diseases.
Fujita Y; Rooney CM; Heslop HE
Bone Marrow Transplant; 2008 Jan; 41(2):193-8. PubMed ID: 17982497
[TBL] [Abstract][Full Text] [Related]
42. Cellular immunotherapy for viral infection after HSC transplantation.
Moss P; Rickinson A
Nat Rev Immunol; 2005 Jan; 5(1):9-20. PubMed ID: 15630425
[TBL] [Abstract][Full Text] [Related]
43. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
Front Immunol; 2018; 9():1129. PubMed ID: 29887865
[TBL] [Abstract][Full Text] [Related]
44. Human cytomegalovirus load measurement and its applications for pre-emptive therapy in patients undergoing hematopoietic stem cell transplantation.
Baldanti F; Lilleri D; Gerna G
Hematol Oncol; 2008 Sep; 26(3):123-30. PubMed ID: 18386849
[TBL] [Abstract][Full Text] [Related]
45. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
46. Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation.
Peggs KS; Thomson K; Samuel E; Dyer G; Armoogum J; Chakraverty R; Pang K; Mackinnon S; Lowdell MW
Clin Infect Dis; 2011 Jan; 52(1):49-57. PubMed ID: 21148519
[TBL] [Abstract][Full Text] [Related]
47. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
[TBL] [Abstract][Full Text] [Related]
48. Cytomegalovirus infection after orthotopic liver transplantation is restricted by a pre-existing antiviral immune response of the recipient.
Bissinger AL; Oettle H; Jahn G; Neuhaus P; Sinzger C
J Med Virol; 2004 May; 73(1):45-53. PubMed ID: 15042647
[TBL] [Abstract][Full Text] [Related]
49. CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus.
Hassan-Walker AF; Vargas Cuero AL; Mattes FM; Klenerman P; Lechner F; Burroughs AK; Griffiths PD; Phillips RE; Emery VC
J Infect Dis; 2001 Mar; 183(6):835-43. PubMed ID: 11237798
[TBL] [Abstract][Full Text] [Related]
50. Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity.
Borysiewicz LK; Graham S; Hickling JK; Mason PD; Sissons JG
Eur J Immunol; 1988 Feb; 18(2):269-75. PubMed ID: 2832181
[TBL] [Abstract][Full Text] [Related]
51. Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection.
Lilleri D; Fornara C; Revello MG; Gerna G
J Infect Dis; 2008 Aug; 198(4):536-43. PubMed ID: 18590456
[TBL] [Abstract][Full Text] [Related]
52. Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease.
Odendahl M; Grigoleit GU; Bönig H; Neuenhahn M; Albrecht J; Anderl F; Germeroth L; Schmitz M; Bornhäuser M; Einsele H; Seifried E; Busch DH; Tonn T
Cytotherapy; 2014 Sep; 16(9):1245-56. PubMed ID: 25108651
[TBL] [Abstract][Full Text] [Related]
53. Helper function of cytolytic lymphocytes: switching roles in the immune response.
Li Pira G; Ivaldi F; Bottone L; Koopman G; Manca F
Eur J Immunol; 2007 Jan; 37(1):66-77. PubMed ID: 17171758
[TBL] [Abstract][Full Text] [Related]
54. Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones.
Riddell SR; Walter BA; Gilbert MJ; Greenberg PD
Bone Marrow Transplant; 1994; 14 Suppl 4():S78-84. PubMed ID: 7728132
[TBL] [Abstract][Full Text] [Related]
55. BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses.
Blyth E; Clancy L; Simms R; Gaundar S; O'Connell P; Micklethwaite K; Gottlieb DJ
Transplantation; 2011 Nov; 92(10):1077-84. PubMed ID: 22002347
[TBL] [Abstract][Full Text] [Related]
56. Monitoring human cytomegalovirus infection in transplant recipients.
Baldanti F; Lilleri D; Gerna G
J Clin Virol; 2008 Mar; 41(3):237-41. PubMed ID: 18203657
[TBL] [Abstract][Full Text] [Related]
57. Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation.
Perruccio K; Topini F; Tosti A; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
Blood Cells Mol Dis; 2008; 40(1):76-83. PubMed ID: 17977031
[TBL] [Abstract][Full Text] [Related]
58. CMV-specific TCR-transgenic T cells for immunotherapy.
Schub A; Schuster IG; Hammerschmidt W; Moosmann A
J Immunol; 2009 Nov; 183(10):6819-30. PubMed ID: 19864595
[TBL] [Abstract][Full Text] [Related]
59. CMV-specific immunotherapy.
Einsele H; Hebart H
Hum Immunol; 2004 May; 65(5):558-64. PubMed ID: 15172457
[TBL] [Abstract][Full Text] [Related]
60. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
